K-numberK250038
Device nameMuscle Stimulator Device (PZ-100)
ApplicantZhengzhou PZ Laser Slim Technology Co., Ltd.
Product codeNGX
Device classClass II
Decision dateMay 19, 2025
DecisionSubstantially Equivalent
Regulation890.5850
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Muscle Stimulator Device (PZ-100) is a non-invasive therapeutic device that produces electromagnetic fields to stimulate muscles. It is indicated for improvement of abdominal tone and muscle strengthening, toning and firming of buttocks, thighs, calves, and arms. The device features a touch screen interface and can apply multiple treatment handles simultaneously, held in place by bandages.

Technological characteristics

The proposed device has four outputs compared to the predicate's two outputs, and is Class I electrical protection versus the predicate's Class II. Both use magnetic field energy with similar field intensities (0.5-1.8 T and 0.7-2.0 T ranges), identical pulse repetition rates (1-150 Hz), and comparable pulse durations around 280 microseconds. Minor differences exist in applicator dimensions, system dimensions, ambient temperature range, and energy source specifications.

Test standards cited

IEC 60601-1:2020, IEC 60601-1-2:2020, IEC 60601-2-10:2016, IEC 60601-1-6:2020 (medical electrical equipment safety), ISO 10993-5:2009, ISO 10993-10:2021, and ISO 10993-23:2021 (biocompatibility testing for cytotoxicity, skin sensitization, and irritation).

Substantial equivalence argument

The device is substantially equivalent because it uses the same principle of action (initiating muscle contraction via nerve stimulation), has identical indications for use, applies the same type of magnetic field energy with comparable intensities and pulse parameters, and meets all the same safety and performance standards. The differences (4 outputs vs. 2, Class I vs. Class II electrical protection, minor dimensional variations) do not raise new safety or effectiveness questions because both devices comply with the same IEC standards and the increased number of outputs does not fundamentally change the mechanism or risk profile.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →